Eisai
4523.T
#832
Rank
$20.25 B
Marketcap
$70.65
Share price
-2.25%
Change (1 day)
18.06%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2022 (TTM): $24.38 M

According to Eisai's latest financial reports the company's current earnings (TTM) are $24.38 M. In 2021 the company made an earning of $0.63 B a decrease over its 2020 earnings that were of $1.04 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$24.38 M-96.17%
2021$0.63 B-39.34%
2020$1.04 B7.3%
2019$0.97 B17.23%
2018$0.83 B86.06%
2017$0.44 B-23.64%
2016$0.58 B27.28%
2015$0.46 B22.08%
2014$0.37 B-42.58%
2013$0.65 B-26.5%
2012$0.89 B-20.72%
2011$1.13 B-8.44%
2010$1.23 B18.85%
2009$1.03 B